鲁抗医药(600789) - 2025 Q2 - 季度业绩预告

Current Period Performance Forecast The company forecasts a 59.34%-65.98% year-on-year decrease in H1 2025 net profit attributable to shareholders, primarily due to prior year non-recurring gains, while core business profitability shows growth 2025 Semi-Annual Performance Forecast | Metric | 2025 Semi-Annual Forecast (million CNY) | Year-on-Year Change | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders of the Parent Company | 102.06 - 121.96 | ↓ 59.34% - 65.98% | | Net Profit Excluding Non-Recurring Gains/Losses | 94.88 - 107.68 | ↑ 3.49% - 17.45% | - The performance forecast data represents preliminary calculations by the finance department and has not been audited by a certified public accountant[3] Prior Period Operating Performance and Financial Status Key financial data for H1 2024, including approximately 300 million CNY in net profit attributable to shareholders and 92 million CNY in net profit excluding non-recurring items, serves as the baseline for current period comparisons H1 2024 Operating Performance | Metric (H1 2024) | Amount (million CNY) | | :--- | :--- | | Net Profit Attributable to Shareholders of the Parent Company | 299.96 | | Net Profit Excluding Non-Recurring Gains/Losses | 91.68 | | Earnings Per Share | 0.33 (CNY) | Key Reasons for Current Period Performance Change The significant year-on-year decline is primarily due to a substantial 156 million CNY non-recurring gain from land disposal in the prior year, with core business profit growing after excluding this impact - Non-recurring gains/losses impact: A 156 million CNY asset disposal gain from the South Plant land transfer in the prior year significantly skewed the net profit base for comparison[6] - Core business impact: The company achieved increased operating profit year-on-year by strengthening excellent performance management and optimizing production, sales, and supply chain processes for quality and efficiency improvements[6] Risk Warning The company confirms no significant uncertainties affecting the accuracy of this performance forecast exist as of the announcement date - As of the announcement date, the company confirms no significant uncertainties affecting the accuracy of this performance forecast[7] Other Explanatory Notes The company reminds investors that this disclosure contains preliminary data, with final financial figures subject to the official 2025 semi-annual report, and advises caution regarding investment risks - This forecast data represents preliminary results, with final accurate figures subject to the company's officially disclosed 2025 semi-annual report[8]